Evidence map›Paper›PMID 42512281›Full record

ArticleCancers2026

Prophylactic PEG-rhG-CSF Reduces Febrile Neutropenia in Pediatric Hematological Malignancies Compared with Daily rhG-CSF.

Xiao Zhang, Yang Fu, Hongsheng Wang, Xiaohua Zhu, Yi Yu, Ping Cao, Chen Shen, Xiaowen Zhai

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiao ZhangDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Yang FuDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Hongsheng WangDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Xiaohua ZhuDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Yi YuDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Ping CaoDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Chen ShenDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.
Xiaowen ZhaiDepartment of Hematology, National Children's Medical Center, Children's Hospital of Fudan University, Shanghai 201102, China.

Funding

National Key R&D Program of China 2022YFC2705003National Natural Science Foundation of China 82141125the Science and Technology Commission of Shanghai Municipality 21Y31900302
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

childefficacyhematological malignanciespegylated recombinant human granulocyte colony-stimulating factorsafety

Identifiers

PMID42512281
PMCPMC13406966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.